PlainBillCongress, translated.Legislation. Context. Public interest.Became Public Law No: 113-233.
Congressional Research Service
Version 49 · Public Law · Dec 16, 2014
(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)
Adding Ebola to the FDA Priority Review Voucher Program Act - (Sec. 2) Amends the Federal Food, Drug, and Cosmetic Act to add filoviruses, a family of viruses that includes the Ebola virus, to the list of tropical diseases under the priority review voucher program, which awards vouchers to sponsors of human drug applications that are approved to prevent or treat tropical diseases. (A voucher entitles the holder to have a future human drug application acted upon by the Food and Drug Administration (FDA) within six months.)
Changes the process by which infectious diseases that do not significantly impact developed nations and disproportionately affect poor and marginalized populations can be designated as tropical diseases from rulemaking to order of the Secretary of Health and Human Services (HHS).
Showing the opening paragraphs of the official summary.
Allows priority review vouchers to be transferred between sponsors of human drug applications any number of times.
Reduces from 365 days to 90 days the advance notice required before submitting a human drug application subject to a priority review voucher.
People & committees
Sen. Harkin, Tom [D-IA] · D–IA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Became Public Law No: 113-233.
Became Public Law No: 113-233.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed without objection. (text: CR H8344)
Passed/agreed to in House: On passage Passed without objection.(text: CR H8344)
Considered by unanimous consent. (consideration: CR H8344)
Mr. Bilirakis asked unanimous consent to take from the Speaker's table and consider.
Held at the desk.
Message on Senate action sent to the House.
Received in the House.
Passed Senate without amendment by Unanimous Consent. (consideration: CR S6271; text as passed Senate: CR S6271)
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S6271; text as passed Senate: CR S6271)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 602.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin without amendment. Without written report.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin without amendment. Without written report.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Primary sources
Text links open the official source. We currently store references to these documents.
Source last updated: Dec 5, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze S.2917 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine S.2917 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine S.2917 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine S.2917 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.